Percutaneous intervention, surgery, and medical therapy: a perspective from the Duke Databank for Cardiovascular Diseases.
Journal Article
Myocardial revascularization improves survival rates and quality of life for patients with symptomatic ischemic heart disease. The less severe the anatomic disease, the smaller the benefit, particularly for survival. Patients with more severe anatomic disease benefit from surgical therapy, in terms of both survival and quality of life. Continuing advances in pharmacological secondary prevention, percutaneous intervention, and surgical treatment mandate continued analysis of contemporary outcomes to provide the best information for rational decision-making.
Full Text
Duke Authors
Cited Authors
- Califf, RM; Mark, DB
Published Date
- April 1, 1994
Published In
Volume / Issue
- 6 / 2
Start / End Page
- 120 - 128
PubMed ID
- 8025138
Pubmed Central ID
- 8025138
Electronic International Standard Serial Number (EISSN)
- 1532-9488
International Standard Serial Number (ISSN)
- 1043-0679
Language
- eng